News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

M's Science Corporation and Eisai Company, Ltd. (ESALY.PK) Sign Option Agreement for Sigma Agonist SA4503



3/12/2008 12:37:31 PM

Tokyo, Japan, Mar 12, 2008 - (JCN Newswire) - M's Science Corporation and Eisai Co., Ltd. (TSE: 4523) announced today that the companies entered into an option agreement for SA4503, a novel sigma agonist which is being developed by M's Science in Europe for the treatment of depression and post-stroke therapy.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES